Autoimmune diseases. SLIDE 3: Introduction to autoimmune diseases Chronic

Similar documents
What will we discuss today?

Test Name Results Units Bio. Ref. Interval

Disclosures. Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies. None

Test Name Results Units Bio. Ref. Interval

Budsakorn Darawankul, MD. Maharat Nakhon Ratchasima Hospital

High Impact Rheumatology

Test Name Results Units Bio. Ref. Interval

The Power of the ANA. April 2018 Emily Littlejohn, DO MPH

LUPUS CAN DO EVERYTHING, BUT NOT EVERYTHING IS LUPUS LUPUS 101 SLE SUBSETS AUTOIMMUNE DISEASE 11/4/2013 HOWARD HAUPTMAN, MD IDIOPATHIC DISCOID LUPUS

Alida R Harahap & Farida Oesman Department of Clinical Pathology Faculty of Medicine, University of Indonesia

Insights into the DX of Pediatric SLE

Definition Chronic autoimmune disease The body s immune system starts attacking itself Can affect most organs and tissues in the body Brain, lungs, he

SCLERODERMA 101. Maureen D. Mayes, MD, MPH Professor of Medicine University of Texas - Houston

Autoimmune Disease. Autoimmunity. Epidemiology. ACR Criteria for Diagnosis. Signs and Symptoms. Autoreactivity: Reactivity to self antigens:

Autoimmunity. Autoimmune Disease

2/23/18. Disclosures. Rheumatic Diseases of Childhood. Making Room for Rheumatology. I have nothing to disclose. James J.

Clinical Laboratory. [None

Policy. Section: Medicine Effective Date: January 15, 2015 Subsection: Pathology/Laboratory Original Policy Date: December 5, 2014 Subject:

MANAGING THE PATIENT WITH POSITIVE ANA

.,Dr Ali Alkazzaz Babylon collage of medicine 2016

Clinical Laboratory. 14:41:00 Complement Component 3 50 mg/dl Oct-18

Immune tolerance, autoimmune diseases

Is it Autoimmune or NOT! Presented to AONP! October 2015!

Autoantibodies panel ANA

Myositis and Your Lungs

9/25/2013 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Disclosures. Clinical Approach: Evaluating CTD-ILD for the pulmonologist. ILD in CTD. connective tissue disease or collagen vascular disease

The Diagnosis of Lupus

NATIONAL LABORATORY HANDBOOK. Laboratory Testing for Antinuclear antibodies

Autoantibodies in the Idiopathic Inflammatory Myopathies

Section: Medicine Effective Date: January 15, 2016 Subsection: Pathology/Laboratory Original Policy Date: December 5, 2014 Subject:

PS + MPs PS - MPs 37% 36% 64% 64%

INTERPRETATION OF LABORATORY TESTS IN RHEUMATIC DISEASE

UNDERSTANDING SYSTEMIC LUPUS ERYTHEMATOSUS

Living with Lupus: An Insider s Perspective

Lupus. Fast facts. What is lupus? What causes lupus? Who gets lupus?

Reporting Autoimmune Diseases in Hematopoietic Stem Cell Transplantation

Tools to Aid in the Accurate Diagnosis of. Connective Tissue Disease

10/6/08. Systemic Lupus Erythematosus. SLE Epidemiology: who is at risk? Margrit Wiesendanger Division of Rheumatology, CUMC.

RHEUMATOLOGY OVERVIEW. Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center

Policy. Background

Mechanisms of Autontibodies

MOLECULAR IMMUNOLOGY Manipulation of immune response Autoimmune diseases & the pathogenic mechanism

University of Pretoria

LUPUS (SLE) MEDICAL SOURCE STATEMENT

Scleroderma. Nomenclature Synonyms. Scleroderma. Progressive Systemic Sclerosis. Systemic Sclerosis. Edward Dwyer, M.D. Division of Rheumatology

Scleroderma. Nomenclature Synonyms. Scleroderma. Progressive Systemic Sclerosis. Systemic Sclerosis. Limited vs. Diffuse Scleroderma.

Cigna Drug and Biologic Coverage Policy

LUPUS. and Associated Conditions LUPUSUK 2018

Clinical Laboratory. 14:42:00 SSA-52 (Ro52) (ENA) Antibody, IgG 1 AU/mL [0-40] Oct-18

Undifferentiated Connective Tissue Disease and Overlap Syndromes. Mark S. Box, MD

Assays. New. New. Combinations. Possibilities. Patents: EP , AU

Essential Rheumatology. Dr Ellen Bruce Consultant Rheumatologist CMFT

LUPUS. and Associated Conditions LUPUSUK 2015

associated conditions a closer look at connective tissue disease and PAH

Inflammatory Myopathies 4 th year MBBS. Marwan Adwan MBChB, MSc, MRCPI, MRCP(rheum) Consultant Rheumatologist

A clinical syndrome, composed mainly of:

Systemic Lupus Erythematosus

. Autoimmune disease. Dr. Baha,Hamdi.AL-Amiedi Ph.D.Microbiology

Introduce the important components of the immune system Show how they interact & protect the body

Jeopardy. What s the rash? $100 $100 $100 $100 $100 $200 $200 $200 $200 $200 $300 $300 $300 $300 $300 $400 $400 $400 $400 $400

Systemic autoimmune diseases

Pharmaceutical pathology

Rheumatology Primer: What Labs and When

Citation The Journal of dermatology, 37(1), available at

SCLERODERMA: An Update. What You Need To Know

Autoimmune diagnostics. A comprehensive product line for the detection of autoantibodies

Serum Biomarker Panel Testing for Systemic Lupus Erythematosus

Advances in Autoantibody Testing & Clinical Applications

Editing file. Color code: Important in red Extra in blue. Autoimmune Diseases

How the Innate Immune System Profiles Pathogens

Diseases of Immunity 2017 CL Davis General Pathology. Paul W. Snyder, DVM, PhD Experimental Pathology Laboratories, Inc.

INFLAMMATORY DISEASES PART I. Immunopathology Part I

Rheumatology 101 A Pediatrician s Guide

We also assessed the diagnostic significance of the SUBJECTS

Clinical Study A Study on Clinical and Pathologic Features in Lupus Nephritis with Mainly IgA Deposits and a Literature Review

3.Autoimmunity. a. Self-recognition of all body components.

Dr. Venkateswari. R. Dr. Janani Sankar s unit Kanchi Kamakoti CHILDS Trust Hospital

LABORATORY STANDARDS IN THE DIAGNOSIS AND THERAPY MONITORING OF SYSTEMIC LUPUS ERYTHEMATOSUS

MP Serum Biomarker Panel Testing for Systemic Lupus Erythematosus and Other Connective Tissue Diseases

Chapter 35 Active Reading Guide The Immune System

Autoimmune (AI) Disorders

New Therapeutic Perspectives in Sjögren's Syndrome

Requirements in the Development of an Autoimmune Disease Amino Acids in the Shared Epitope

Residual Functional Capacity Questionnaire SYSTEMIC LUPUS ERYTHEMATOSUS

Autoimmunity. Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens

Serum Biomarker Panel Testing for Systemic Lupus Erythematosus and Other Connective Tissue Diseases

Medical Immunology Dr. Hassan Abul Raghib Lecture 16

What is Autoimmunity?

What is Autoimmunity?

Scleroderma Facts. The Scleroderma Foundation is here to help!

Arthritis & Rheumatology Clinics of Kansas PATIENT EDUCATION SYSTEMIC LUPUS ERYTHEMATOSUS

CIBMTR Center Number: CIBMTR Recipient ID: RETIRED. Today s Date: Date of HSCT for which this form is being completed: &

Rheumatologic Lab Tests

Amino acid sequences in the β chain HLA- DRB*0401 molecules dictate susceptibility to RA Amino Acids in the Shared Epitope

Early diagnosis of systemic lupus erythematosus in primary care by family doctors

AMPLIADO SÍNDROME ANTIFOSFOLÍPIDO SÍNDROME DE SJÖGREN María José Cuadrado Lozano Clínica Universidad de Navarra-Madrid

SLE-key Case Studies

AUTOIMMUNE DISORDERS IN THE ACUTE SETTING

3.Autoimmunity. a. Self-recognition of all body components. a. Auto-antibody directed against a self antigen.

Transcription:

SLIDE 3: Introduction to autoimmune diseases Chronic Autoimmune diseases Sometimes relapsing : and remitting. which means that they present as attacks Progressive damage Epitope spreading more and more damage : As it damages more tissue, the antigens that induce unwanted immune response increase leading to more damage Actions may be by: -autoantibodies -Th1 & Th17 cells -CD8 cells -both cellular and humoral SLIDE 4: Autoimmune diseases may be Systemic Tend to involve: - connective tissues -blood vessels (we call them:collagen vascular diseases & connective tissue diseases ) examples: SLE, systemic sclerosis, polymyositis.. etc We will discuss some of these Organ-specific SLIDE 5. Examples Systemic lupus erythematosus (SLE) Sjogren syndrome Systemic sclerosis SLIDE 6 Systemic lupus erythematosus (SLE) Features: - Autoantibodies/immune complexes : Antibodies bind self-antigens leading to the formation of immune complexes that cause damage to the tissue. We call this reaction (Type III hypersensitivity) - Onset: acute or insidious - Typically: chronic, remitting and relapsing - Often febrile illness - 20s & 30s - F:M ratio: 9:1 in reproductive age : Before and after reproductive age the ratio decreases to 2:1 - Blacks & Hispanics more Can affect: * Skin joints kidney serosal membrane any other organ

The American college of rheumatology made this criteria to diagnose a patient with SLE. The patient must meet 4 out of the 11 1. Inflammation in the pleurae, pericardium or peritoneum. When we use the stethoscope we can hear a click at the end of inspiration, which is called a pleural rub. it accompanies pleuraitis There's also pericardial rub that occurs with pericarditis 2. In SLE oral ulcers are PAINLESS 3. Affects 2 joints and more. non erosive with effusion in the joint, erythema and swelling 5. blood cells also get attacked by the immune complexes leading to leukopenia, lymphopenia, thrombocytopenia, hemolytic anemia 6. -presistant proteinuria (more than 0.5 g/dl protein in the urine OR +3 on spot urine test) - presence of cellular cast in the urine. From google: (Urinary casts are tiny tube-shaped particles that can be found when urine is examined under the microscope during a test called urinalysis) 7. Most important ANAs in SLE are: Anti-dsDNA & Anti-smith antibodies *Anti non-histone proteins sub types: - Anti-smith(Anti-Sm)/ Anti-ro(SS-A) / Anti-la(SS-B) elevated. such as: - Anti histone protein antibodies - Anti dsdna antibodies - Anti non-histone proteins antibodies (ribonucleoproteins) - Anti-Nucleolus Antibodies - Anti-centromere antibodies 9. like seizures or psychosis(impaired relationship with reality). *make sure it's not caused by other reasons such as drugs. 10. Butterfly appearance, sparing the nasolabial fold. (The picture on the left) 11. Elevated crusty patches appears mainly in the face and scalp. (The picture on the right)

SLIDE 9. Investigations, indirect immunofluorescence: We use this test -that we talked about before- to detect the ANAs. Each group of the ANAs has a specific pattern Homogenous : used for: AntiHistone and Anti dsdna antibodies. There's another pattern for the Anti dsdna called peripheral. Speckled : For Anti non-histone proteins Centromeric : for anti-centromere antibodies Nucleolar: for Anti-nucleolus antibodies SLIDE 10. Investigations, cont d Antibodies to double-stranded DNA and the so-called Smith (Sm) antigen are virtually diagnostic of SLE In addition to ANAs, 30-40% of lupus patients also have autoantibodies against proteins complexed with phospholipids Plasma proteins: -prothrombin -annexin V -Beta 2-glycoprotein I : Its Ab also binds to cardiolipin antigen Antibodies againt Beta 2-glycoprotein also bind cardiolipin antigen which is found in Treponema pallidum the bacteria that causes syphilis. So patients with SLE might have false positive tests for syphilis because they have antibodies againt the antigen that is found in Treponema pallidum. -protein S -Protein C Lupus anticoagulant?anti-phospholipid antibodies are also called lupus anticoagulants because in vitro they increase the PTT. BUT in reality they are associated with hypercoagulation in the patient. And that's why patients with anti-phospholipid antibodies are prone to recurrent miscarriages.

SLIDE 11. Risk factors Genetic susceptibility HLA-DQ polymorphisms inherited deficiencies of C2, C4, or C1q : Because C2 & C4 are important in removing immune complexes. C1q is important in phagocytosis of apoptitic cells, so impairment in it's function increases antigens that induce immune response. others Environmental factors are more important UV light and drugs : UV light destroys cells,induces apoptosis and causes changes in the DNA to make it antigenic and immunogenic. It also induces fromation of IL-1 by keratinocytes which induces inflammation. Immunological factors: -Failure of self-tolerance in B cells : Main factor in SLE. Leads to formation of autoantibodies and Type III hypersensitivity which we mentioned earlier -CD4+ helper T cells -Role of TLRs : have a role in inflammation (innate immunity) and stimulating B lymphocytes. *B cells have TLR and Fc receptors -Role of type I interferons : Released mainly by dendritic cells -Role of BAFF: Type of the TNF family. has a role in activation and survival of B lymphocytes SLIDE 12. Mechanisms Systemic lesions mostly by type III hypersensitivity: mainly in the kidney causing lupus nephritis. Opsonization of blood cells by autoantibodies Antiphospholipid antibody syndrome : Could be primary, if it's present alone. Or secondary if it's present as part of SLE. One of the important causes of recurrent miscarriages SLIDE13. Sjogren syndrome: Autoimmune diseases in which there's lymphocytic infiltration of the glandular epithelium of the lacrimal and salivary glands leading to dry eyes and dry mouth Most commonly in women between the ages of 50 and 60 Dry eyes (keratoconjunctivitis sicca) and dry mouth (xerostomia) Primary or secondary : If it accompanies another autoimmune disease, mainly: Rheumatoid arthritis. Lymphocytic infiltration and fibrosis of lacrimal and salivary glands : lymphocytic infiltration of the salivary gland is one of the main marks of the disease Mainly CD4+ and B cells : Starts as polyclonal infiltration 75% are positive for rheumatoid factor : Even if it's Primary and the patient doesn't have rheumatoid arthritis ANAs in 50-80% To diagnose the patient with Sjogren syndrome we take a biopsy (slide 16) The most important antibodies are: But not specific. because they might be elevated in SLE SS-A(-earlier onset -longer disease duration -extraglandular manifestations)( Anti-Ro)( Affects prognosis leads to worse prognosis) & SS-B 90% (Anti-la) HLA association Viral infection may be the initial trigger

Sjogren syndrome-like disease is seen in some patients with AIDS & hepatitis C Extraglandular disease in 1/3 of patients -synovitis -pulmonary fibrosis -neuropathy SLIDE16 Biopsy of the lip : we took a biopsy from the lip because lips have minor salivary glands. duct looking abnormal because metaplastic changes occurred late in the course of the disease we can see fibrosis around the duct when lymphocytes invade the duct epithelium we call it histologically: lymphoepithelial lesion. ------------------------- In some cases, if we stain this lesion by immunohistochemical stain and we find that all the cells are CD20+ and CD3 negative (Monoclonal) then we suspect lymphoma, which might exacerbate Sjogren syndrome. In this case the lymphoma is called (Extranodal marginal zone B cell lymphoma). SO sjogren syndrome might be followed by lymphoma. ---------------------------- Extranodal marginal zone B cell lymphoma can also occur in the thyroid gland as an exacrebation of Hashimoto Thyroiditis. ---------------------------- *CD20 is a marker for B cells SLIDE 17 Systemic sclerosis (scleroderma) 50s-60s M:F 1:3 Its distinctive features are the striking cutaneous changes, notably skin thickening : because of the fibrosis by collagen 3 main problems: -Inflammation : CD4+ also humoral roles -Small blood vessel damage : Leads to malignant hypertension -Interstitial and perivascular fibrosis in skin and other tissues The majority: also kidney, heart, lung and GI involvement but late

Diffuse(Affects most of the skin, and the extra-cutaneous involvement is early) VS limited(may affect forearms or fingers.. etc, with late extra-cutaneous involvement) scleroderma : Some patients: CREST syndrome C: calcinosis (soft tissue masses made by calcium) R: Raynaud phenomenon E: esophageal dysmotility S: sclerodactyly T: telangiectasia Raynaud phenomenon virtually in all patients precedes other manifestations in 70% of the cases Dysphagia is an important symptom 50% Nephrotic syndrome is rare The most dangerous risk: malignant hypertension SLIDE 20 Two ANAs are important in diagnosing systemic sclerosis 1- against DNA topoisomerase I (anti-scl 70) highly specific 10-20% of diffuse disease prognostically important : If it's positive then the prognosis is bad. 2-anticentromere antibody 20-30% more with CREST syndrome